Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids

ClinicalTrials.gov ID: NCT05952856

Public ClinicalTrials.gov record NCT05952856. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 11:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-0616 in Adults With Hypercholesterolemia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this study is to evaluate the efficacy, safety, and tolerability of enlicitide decanoate in adult participants with hypercholesterolemia. The primary hypothesis is that enlicitide decanoate is superior to placebo on mean percent change from baseline in low-density lipoprotein cholesterol (LDL-C) at Week 24.

Study identification

NCT ID
NCT05952856
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
2,912 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 10, 2023 (Actual)
Primary completion
Jul 28, 2025 (Actual)
Completion
Jul 28, 2025 (Actual)
Last update posted
Sep 24, 2026

2023 – 2025

United States locations

U.S. sites
49
U.S. states
25
U.S. cities
48
Facility City State ZIP Site status
Alliance for Multispecialty Research, LLC ( Site 0093) Daphne Alabama 36526 —
G&L Research ( Site 0043) Foley Alabama 36535 —
Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0084) Phoenix Arizona 85020 —
National Heart Institute-Research ( Site 0087) Beverly Hills California 90211 —
Clinical Trials Research ( Site 0115) Sacramento California 95821 —
Velocity Clinical Research, Banning ( Site 0017) San Bernardino California 92408 —
Emerson Clinical Research Institute ( Site 0118) Washington D.C. District of Columbia 20009 —
Excel Medical Clinical Trials ( Site 0053) Boca Raton Florida 33434 —
Alliance for Multispecialty Research, LLC ( Site 0088) Coral Gables Florida 33134 —
Alliance for Multispecialty Research, LLC ( Site 0094) Fort Myers Florida 33912 —
Velocity Clinical Research, Hallandale Beach ( Site 0018) Hallandale Florida 33009 —
Jacksonville Center for Clinical Research ( Site 0049) Jacksonville Florida 32216 —
South Broward Research ( Site 0051) Miramar Florida 33027 —
Clinical Research Trials of Florida ( Site 0063) Tampa Florida 33607 —
East Coast Institute for Research, LLC ( Site 0033) Macon Georgia 31210 —
Healthcare Research Network - Chicago ( Site 0052) Flossmoor Illinois 60422 —
Synexus Clinical Research US, Inc. ( Site 0109) Evansville Indiana 47714 —
Midwest Institute For Clinical Research ( Site 0059) Indianapolis Indiana 46260 —
Alliance for Multispecialty Research, LLC ( Site 0028) Lexington Kentucky 40509 —
L-MARC Research Center ( Site 0001) Louisville Kentucky 40213 —
Velocity Clinical Research, Covington ( Site 0068) Covington Louisiana 70433 —
Velocity Clinical Research Rockville ( Site 0082) Rockville Maryland 20854 —
Velocity Clinical Research, Gulfport ( Site 0039) Gulfport Mississippi 39503 —
Healthcare Research Network - St. Louis ( Site 0054) Hazelwood Missouri 63042 —
Jubilee Clinical Research ( Site 0106) Las Vegas Nevada 89106 —
AB Clinical Trials ( Site 0070) Las Vegas Nevada 89119 —
New Mexico Clinical Research & Osteoporosis Center ( Site 0005) Albuquerque New Mexico 87106 —
Velocity Clinical Research, Syracuse ( Site 0021) East Syracuse New York 13057 —
Icahn School of Medicine at Mount Sinai-Cardiology ( Site 0002) New York New York 10029 —
Lillestol Research ( Site 0026) Fargo North Dakota 58104 —
altoona center for clinical research ( Site 0089) Duncansville Pennsylvania 16635 —
Cardiology Consultants of Philadelphia Yardley ( Site 0097) Yardley Pennsylvania 19067 —
Piedmont Research Partners ( Site 0090) Fort Mill South Carolina 29707 —
Velocity Clinical Research, Greenville ( Site 0023) Greenville South Carolina 29615 —
Coastal Carolina Research Center ( Site 0006) North Charleston South Carolina 29405 —
Monument Health Clinical Research, a department of Monument -Monument Health Clinical Research, a d ( Site 0009) Rapid City South Dakota 57701 —
Holston Medical Group ( Site 0048) Kingsport Tennessee 37660 —
Alliance for Multispecialty Research, LLC ( Site 0008) Knoxville Tennessee 37920 —
Velocity Clinical Research, Dallas ( Site 0114) Dallas Texas 75230 —
Center for Cardiometabolic Disease Prevention/Baylor College of Medicine ( Site 0111) Houston Texas 77030 —
Clinical Trials of Texas, LLC ( Site 0103) San Antonio Texas 78229 —
Synexus Clinical Research US, Inc. ( Site 0110) Salt Lake City Utah 84106 —
Velocity Clinical Research, Salt Lake City ( Site 0019) West Jordan Utah 84088 —
Manassas Clinical Research Center ( Site 0007) Manassas Virginia 20110 —
Health Research of Hampton Roads, Inc. ( Site 0044) Newport News Virginia 23606 —
Alliance for Multispecialty Research, LLC ( Site 0101) Norfolk Virginia 23502 —
National Clinical Research, Inc ( Site 0061) Richmond Virginia 23294 —
Centricity Research Suffolk Family Medicine ( Site 0092) Suffolk Virginia 23435 —
Rainier Clinical Research Center ( Site 0116) Renton Washington 98057 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 119 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05952856, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 24, 2026 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05952856 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →